Novogene Co., Ltd. (SHA:688315)
China · Delayed Price · Currency is CNY 15.55
-0.45 (-2.81%)
May 12, 2026, 3:00 PM CST
Novogene Market Cap
Novogene has a market cap or net worth of 6.3 billion as of May 12, 2026. Its market cap has increased by 14.68% in one year.
Market Cap
6.30B
Enterprise Value
4.77B
Revenue
2.26B
Ranking
n/a
PE Ratio
38.89
Stock Price
15.55
Market Cap Chart
Since April 13, 2021, Novogene's market cap has decreased from 10.97B to 6.30B, a decrease of -42.56%. That is a compound annual growth rate of -10.34%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 12, 2026 | 6.30B | 17.09% |
| Dec 31, 2025 | 5.38B | 6.24% |
| Dec 31, 2024 | 5.06B | -47.88% |
| Dec 29, 2023 | 9.71B | -8.02% |
| Dec 30, 2022 | 10.56B | -36.10% |
| Dec 31, 2021 | 16.53B | 50.73% |
| Apr 13, 2021 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Wuhan Keqian Biology Co.,Ltd | 6.90B |
| Anhui Huaheng Biotechnology | 6.84B |
| Innovita Biological Technology | 6.83B |
| Shouyao Holdings (Beijing) Co., LTD. | 6.19B |
| Hangzhou Biotest Biotech | 6.08B |
| R&G PharmaStudies | 5.87B |
| PharmaResources (Shanghai) | 5.86B |
| Lifecome Biochemistry | 5.86B |